A Patent Decision on Crispr Gene Editing Favors MIT
A Patent Decision on Crispr Gene Editing Favors MIT
Science, Spoken · SpokenLayer
February 17, 20177m 32s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The fight over who owns the most promising technique for editing genes-cutting and pasting the stuff of life to cure disease and advance scientific knowledge-has been a rough one. A team on the West Coast, at UC Berkeley, filed patents on the method, Crispr-Cas9; a team on the East Coast, based at MIT and the Broad Institute, filed their own patents in 2014 after Berkeley's, but got them granted first.
Learn about your ad choices: dovetail.prx.org/ad-choices